EUVIMEDEUVIMED entdecken
Open Access

Naringenin Inhibits Colorectal Cancer associated with a High-Fat Diet through Modulation of Gut Microbiota and IL-6/STAT3 Pathway

Jiahui Sun, Luyao Shi, Fan Xu, Hanyan Sun, Yitong Liu, Jiangyun Sun, Qingxin Zhou

Journal of Microbiology and Biotechnology · 2025

DOI: 10.4014/jmb.2412.12029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Jiahui Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China. Hauptthemen laut MEDLINE: Flavanones, Gastrointestinal Microbiome, Colorectal Neoplasms, STAT3 Transcription Factor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a worldwide health issue. It causes illness and death in millions of people each year. A positive correlation has been observed between the intake of dietary fat and the development of CRC. The composition of gut microbiota exhibits a significant correlation with pathophysiologic processes in intestine. Clinical treatment remains inadequate due to the complex pathogenic mechanisms of CRC triggered by a high-fat diet (HFD). Naringenin, a flavonoid from grapefruit, has anti-cancer activity. Our findings suggest that naringenin enhances gut microbiota diversity by increasing the abundance of beneficial bacterial species while reducing opportunistic pathogenic bacteria. The fecal microbiota transplantation assay (FMT) demonstrated that the anti-HFD-CRC activity of naringenin depended on the gut microbiota. Furthermore, naringenin antagonized the IL-6/STAT3 pathway. These results suggest that naringenin may be a potential treatment for HFD-CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesGastrointestinal MicrobiomeColorectal NeoplasmsSTAT3 Transcription FactorDiet, High-FatInterleukin-6AnimalsMiceMaleSignal TransductionFecal Microbiota TransplantationHumansMice, Inbred C57BLBacteria

Stichwörter der Autor:innen

IL-6/STAT3 pathwayNaringenincolorectal cancergut microbiotahigh-fat diet

Substanzen

FlavanonesnaringeninSTAT3 Transcription FactorInterleukin-6

Autor:innen und Institutionen

  • Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China.
  • Department of Medical oncology, Xianyang Central Hospital, Xianyang, Shanxi 712000, P.R. China.
  • Department of acupuncture, 1st Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, P.R. China.

Zitieren

APA

Sun, J., Shi, L., Xu, F., Sun, H., Liu, Y., Sun, J., & Zhou, Q. (2025). Naringenin Inhibits Colorectal Cancer associated with a High-Fat Diet through Modulation of Gut Microbiota and IL-6/STAT3 Pathway. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2412.12029

Vancouver

Sun J, Shi L, Xu F, Sun H, Liu Y, Sun J, et al. Naringenin Inhibits Colorectal Cancer associated with a High-Fat Diet through Modulation of Gut Microbiota and IL-6/STAT3 Pathway. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2412.12029

BibTeX
@article{Sun2025,
  author = {Sun, Jiahui and Shi, Luyao and Xu, Fan and Sun, Hanyan and Liu, Yitong and Sun, Jiangyun and Zhou, Qingxin},
  title = {Naringenin Inhibits Colorectal Cancer associated with a High-Fat Diet through Modulation of Gut Microbiota and IL-6/STAT3 Pathway},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.4014/jmb.2412.12029}
}
Kostenlos starten →